INTRODUCTION
Radiolabeled molecular probes have long been used to study various molecular events in biological systems. The invention of gamma cameras, single photon emission computerized tomography and PET allowed application of probes labeled with gamma-or positron-emitting radioisotopes for physiological or molecular imaging in living subjects, from small animals to humans. However, in preclinical studies, tissue biodistribution assays and DWBA still play an important role in determining specific tissue accumulation of radiolabeled probes at a single time point and with high sensitivity in research animals. Tissue biodistribution studies are useful for detection of low-level probes in the tissues of research animals, and the procedures do not require any expensive instrumentation. However, the disadvantages of this assay are that one can only determine the biodistribution of a probe in an animal at a single time point and it may take several days to obtain the results. DWBA has the same disadvantages, but it can provide highresolution tomographs of a probe's tissue accumulation at the time the research animal is killed for analysis.
In this protocol, we describe procedures for tissue biodistribution analysis and DWBA assay of a PRP in mice. Examples of common reporter probes used for the detection of HSV1-tk or mutant HSV1-sr39tk PRG expression include [ [1] [2] [3] [4] [5] . We have provided detailed backgrounds of these PRP/PRG systems in two previous Nature Protocols publications [6] [7] [8] . In addition to enabling high resolution and sensitivity detection of PRGs, tissue biodistribution analysis and DWBA allow the study of pharmacokinetics of any novel radiolabeled probe. These studies can also be used to confirm the results of animal SPECT or PET imaging 9 .
Reporter probe biodistribution studies are often performed using mouse models designed to express PRGs in specific parts of their body. For example, tumors may have been implanted in these mice that stably express these PRGs, or the PRGs may have been delivered to specific tissues with transgene delivery vectors. Otherwise, one may study the biodistribution of any beta-or gamma/positronradiolabeled probe in a normal mouse. This is often done to evaluate the pharmacokinetics of new probes before testing them for target specificity in animal studies. Scintillation counter calibration Scintillation counters only count a percentage of the total disintegrations from b + emissions. Therefore, it is important to determine the efficiency factors of the scintillation counter for tritium. This can be determined by using a tritium standard vial (having a known amount of activity) and counting the vial and then calculating the percentage of the known activity equivalent to the actual count. The Beckman Coulter LS6500 in our laboratory has an efficiency factor of 59.2% for tritium and 78.7% for 14 C. The counting efficiency of the gamma counter should also be determined.
PROCEDURE
Analyzing the biodistribution of radiolabeled HSV1-tk/HSV1-sr39tk reporter probes in mice 1| Administer the appropriate amount of the radiolabeled probe into the mouse. ! CAUTION All animal experiments should be performed in accordance with relevant guidelines and regulations of protocols approved by your institution's animal research review committees. Also, you should be trained to work with radioisotopes before starting the following studies.
2| At the desired analysis time after probe administration, perform either (A) a tissue biodistribution assay or (B) a DWBA assay after killing the mouse using an approved method. m CRITICAL STEP It is important to leave the specimen in liquid nitrogen long enough to ensure thorough freezing, yet not so long that the specimen starts to crack. (viii) To remove the tail, use strong scissors or wire cutters to snip the tail one centimeter away from the body, while the specimen is still frozen. (ix) Immediately place the specimen in CMC and push firmly until the subject is lying on the falcon end caps. Be sure the specimen is positioned so that the blade will slice from anterior to posterior. Add CMC to cover the entire specimen. Squeeze out any large air bubbles that might still be in the CMC. (x) Place the entire chuck-CMC-specimen construct into the remaining liquid nitrogen and allow it to freeze for 10 min.
Add more liquid nitrogen if necessary. (xi) Remove the construct from liquid nitrogen and store at À20 1C for at least 1 h. The specimen is now ready to be sliced.
The attached movie illustrates the process of DWBA (Supplementary Video 1 online) . (xii) Animal sectioning. Oil all moving parts of the macrotome, including the metal rails, the elevator arms and the wells.
! CAUTION The Leica macrotome has a very sharp blade. Whenever you use the cryostat, you need to be alert and be careful not to have your arms or hands in front of the blade. (xiii) Place the chuck into the macrotome and adjust it so that it is level. Secure the chuck tightly. (xiv) Raise the blade to the highest level of the CMC. (xv) Begin slicing at 100-200 mm thickness until the subject begins to become exposed. The slices must be thin enough to prevent chipping. When the subject becomes exposed, reduce the slice thickness to 45 mm. Periodically check the chuck to make sure it is still at level. (xvi) When a desired slice is reached, place a ruler on the CMC next to the subject and photograph the entire region with a digital camera. Mark the first slice with the specimen name and date. (xvii) Place a layer of label guard tape over the entire specimen and apply firm pressure on the entire surface. Leave 2-3 inches of exposed tape on the end closest to the blade. (xviii) Hold the end of the tape closest to the blade, while using your knees to move the slicer and guide the tape off the blade.
Do not pull on the tape since the slice may tear or fall off the tape. (xix) Set the slice on a tray next to the blade.
! CAUTION Any extended duration of warmth will melt the slice and render it useless; thus, it is important to keep the slice inside the macrotome at all times. (xx) Place as many slices that will fit into a cartridge and record the order. Cover a blanked digital film (a digital film that has been cleared of radiographs, using a light exposure device) with Saran wrap and place over the slices, facing the slices. m CRITICAL STEP Make sure that you use a blanked digital film. (xxi) Close the cartridge and store at À20 1C.
(xxii) Film development. Allow the films to develop for the appropriate amount of time to yield good images and remove from the À20 1C storage. For 18 F-conjugated probes, we usually expose the films to slices overnight, and for iodine-124 probes 7-9 h of exposure usually yields good images. Tritium and 14 C probes require very long exposure times (2-3 months and several weeks, respectively). ? TROUBLESHOOTING ? TROUBLESHOOTING To avoid the problem of underexposing the films, it would be good to have two or three test plates, which can be kept exposed in the freezer for a longer time period. This still works, because tissue sections are only a few micrometers apart. Also, be careful not to contaminate the plate with your fingers/gloves, which might have touched the radioactive samples.
ANTICIPATED RESULTS
Tissue biodistribution assays and DWBA are useful for analyzing the accumulation of probes in the tissues of research animals at a single time point only, but offer the advantage of higher sensitivity and in the case of DWBA higher resolution (B100 mm with 45 mm slices) tomographs than with microPET imaging. Biodistribution assays and microPET imaging allow quantification of activity in tissues as a percentage of injected dose. The degree of accumulation of reporter probes in tissues expressing the HSV1-tk/HSV1-sr39tk PRGs relative to background depends on the transport of these probes into cells, the extent of HSV1-tk/HSV1-sr39tk enzyme-catalyzed phosphorylation of the probe and the extent of probe phosphorylation by mammalian thymidine kinase enzymes. In addition, probe activity will be detected in the organs involved in clearance of the probe 
